Nothing Special   »   [go: up one dir, main page]

Bergström et al., 2001 - Google Patents

Dopamine transporter in vitro binding and in vivo imaging in the brain

Bergström et al., 2001

View PDF
Document ID
736456411488635009
Author
Bergström K
Tupala E
Tiihonen J
Publication year
Publication venue
Pharmacology & Toxicology: MiniReview

External Links

Snippet

Much research interest has lately been focused on the dopamine transporter function in brain. Recent findings indicate that dopamine reuptake is more like a highly regulated than a constitutive determinant of dopamine clearance. Positron emission tomography (PET) and …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Volkow et al. PET evaluation of the dopamine system of the human brain
Kasper et al. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder—implications for psychopharmacology
Sabri et al. Acetylcholine receptors in dementia and mild cognitive impairment
Heiss et al. Brain receptor imaging
Ametamey et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688
Smith et al. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects
Kung et al. IPT: a novel iodinated ligand for the CNS dopamine transporter
Bergström et al. 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies
Stathis et al. Rate of binding of various inhibitors at the dopamine transporter in vivo
Zimmer et al. Effect of endogenous serotonin on the binding of the 5‐HT1A PET ligand 18F‐MPPF in the rat hippocampus: kinetic β measurements combined with microdialysis
Guilloteau et al. Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl) nortropane (PE2I)
Ichise et al. Imaging of β-cell mass and function
Emond et al. PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter
Saigal et al. Evaluation of serotonin 5‐HT1A receptors in rodent models using [18F] mefway PET
Jung et al. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol
Mukherjee et al. Comparative assessment of 18F‐Mefway as a serotonin 5‐HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans
Varlow et al. Classics in neuroimaging: imaging the endocannabinoid pathway with PET
Eckelman The Development of Single-photon Emitting Receptorbinding Radiotracers
Gatley et al. In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F] fluoronorchloroepibatidine in rodent and human brain
Ding et al. Dopamine receptor‐mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro [18F] fluoroepibatidine
Bergström et al. Dopamine transporter in vitro binding and in vivo imaging in the brain
Yoshimura et al. Development of 99mTc-labeled pyridyl benzofuran derivatives to detect pancreatic amylin in islet amyloid model mice
Elsinga Nuclear medicine imaging tracers for neurology
Karlsson et al. Systematic screening of imaging biomarkers for the Islets of Langerhans, among clinically available positron emission tomography tracers
Nag et al. Development of a Novel [11C] CO-Labeled Positron Emission Tomography Radioligand [11C] BIO-1819578 for the Detection of O-GlcNAcase Enzyme Activity